Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger FYVE-type containing protein 21 (ZFYVE21) is a member of the FYVE-type zinc finger protein family, characterized by the presence of a FYVE domain that allows binding to phosphoinositides. ZFYVE21 is involved in the regulation of cell adhesion and motility by contributing to the assembly and disassembly of focal adhesions, cellular structures critical for attaching cells to the extracellular matrix and for signaling. ZFYVE21 plays a regulatory role in microtubule-induced dephosphorylation of focal adhesion kinase (PTK2/FAK1), a process important for the disassembly of these adhesions and for integrin beta-1 surface expression. Its function links it to cell movement and possibly cancer metastasis due to its established role in focal adhesion dynamics. There are no established drug interactions, biomarker applications, or well-defined safety concerns reported for this target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger FYVE-type containing protein 21 (ZFYVE21).